Collaborate with Us

We want to partner with organisations who wish to increase adoption of advanced therapeutics such as gene therapies.

We want to hear from you if, together, we can speed up our pathway from the lab to the patient, and reduce barriers to clinical uptake of innovative treatments.

 

Partnership opportunities

We want to partner with diverse organisations ranging from: 

  • Academic research sector
  • Industry community - biotech, pharma, medtech, CDMOs, diagnostics, data/AI
  • Third sector - charitable, patient and philanthropic organisations

We are experienced in working with external partners, including industry, tailoring each collaboration to deliver mutual benefits.

 

We are seeking partner organisations:

  • With complementary research portfolio, technologies, datasets, models and platforms
  • Who can help accelerate readiness for pre- and clinical studies
  • Who can assist with removal of adoption bottlenecks by health systems and patient communities

Research Environment

Find out the benefits of collaborating with us and becoming a partner organisation.

Technologies and network graphic

Co-developing technologies

Jointly develop new tools, methods and complementary intellectual property (IP) to existing technologies aligned to clinical needs.

Edinburgh Genome Foundry Robots

Access and sharing resources

Sharing of materials, access to specialist facilities and technology platforms , licensing of intellectual property (IP), tools and methods.

Scientists working in a lab

Training

 

Knowledge transfer and upskilling of staff through staff exchanges, secondments, visits, and training to build long-term capability.

Thriving Network

Folders on a desk

Leveraging funding

Joint bids for translational research and development funding on competitive funding calls (e.g., UKRI, Innovate UK, Horizon Europe, NIHR) and targeted philanthropic funding opportunities.

people in a working group

Sector advocacy

Inputting in activities (e.g. working groups) that aim to address pain points for the adoption of advanced therapeutics to the benefit of the wider sector and patients.

communication network graphic

Dissemination

Communicating our work and enabling the dissemination of key outputs to key audiences.

 

Contact Us

If you are interested in collaborating with us, get in touch.

Dr Alice Barrier

Head of Operations- Advanced Therapeutics Hub

  • Mission Hub for Engineered Genetic Control Systems for Advanced Therapeutics
  • School of Biological Sciences

Contact details